Logo image of NVTA

INVITAE CORP (NVTA) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:NVTA - US46185L1035 - Common Stock

0.0891 USD
-0.3 (-77.12%)
Last: 2/5/2024, 7:40:05 PM
Fundamental Rating

2

Overall NVTA gets a fundamental rating of 2 out of 10. We evaluated NVTA against 100 industry peers in the Health Care Providers & Services industry. NVTA may be in some trouble as it scores bad on both profitability and health. NVTA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

NVTA had negative earnings in the past year.
NVTA had a negative operating cash flow in the past year.
NVTA had negative earnings in each of the past 5 years.
In the past 5 years NVTA always reported negative operating cash flow.
NVTA Yearly Net Income VS EBIT VS OCF VS FCFNVTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -1B -2B -3B

1.2 Ratios

With a Return On Assets value of -269.22%, NVTA is not doing good in the industry: 96.49% of the companies in the same industry are doing better.
With an excellent Return On Invested Capital value of 381.98%, NVTA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
ROA -269.22%
ROE N/A
ROIC 381.98%
ROA(3y)-61.41%
ROA(5y)-52.18%
ROE(3y)-1031.52%
ROE(5y)-647.66%
ROIC(3y)N/A
ROIC(5y)N/A
NVTA Yearly ROA, ROE, ROICNVTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 -1K -2K -3K

1.3 Margins

NVTA has a better Operating Margin (378.20%) than 100.00% of its industry peers.
NVTA has a Gross Margin of 27.14%. This is comparable to the rest of the industry: NVTA outperforms 51.75% of its industry peers.
In the last couple of years the Gross Margin of NVTA has declined.
Industry RankSector Rank
OM 378.2%
PM (TTM) N/A
GM 27.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.59%
GM growth 5Y-3.73%
NVTA Yearly Profit, Operating, Gross MarginsNVTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 -200 -400 -600 -800 -1K

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), NVTA is creating value.
The number of shares outstanding for NVTA has been increased compared to 1 year ago.
NVTA has a worse debt/assets ratio than last year.
NVTA Yearly Shares OutstandingNVTA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M
NVTA Yearly Total Debt VS Total AssetsNVTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of -3.51, we must say that NVTA is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -3.51, NVTA is doing worse than 86.84% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.51
ROIC/WACC172.06
WACC2.22%
NVTA Yearly LT Debt VS Equity VS FCFNVTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 1B 2B

2.3 Liquidity

NVTA has a Current Ratio of 2.39. This indicates that NVTA is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of NVTA (2.39) is better than 79.82% of its industry peers.
A Quick Ratio of 2.25 indicates that NVTA has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.25, NVTA is in the better half of the industry, outperforming 78.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 2.25
NVTA Yearly Current Assets VS Current LiabilitesNVTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 58.74% over the past year.
The Revenue has decreased by -7.37% in the past year.
The Revenue has been growing by 49.91% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)58.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.19%
Revenue 1Y (TTM)-7.37%
Revenue growth 3Y33.54%
Revenue growth 5Y49.91%
Sales Q2Q%-9.21%

3.2 Future

NVTA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.71% yearly.
NVTA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.73% yearly.
EPS Next Y53.25%
EPS Next 2Y26.21%
EPS Next 3Y18.34%
EPS Next 5Y12.71%
Revenue Next Year-6.03%
Revenue Next 2Y0.81%
Revenue Next 3Y3.75%
Revenue Next 5Y3.73%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NVTA Yearly Revenue VS EstimatesNVTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
NVTA Yearly EPS VS EstimatesNVTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -1 -2 -3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

NVTA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NVTA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NVTA Price Earnings VS Forward Price EarningsNVTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

98.25% of the companies in the same industry are more expensive than NVTA, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.53
NVTA Per share dataNVTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2 -3

4.3 Compensation for Growth

A more expensive valuation may be justified as NVTA's earnings are expected to grow with 18.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.21%
EPS Next 3Y18.34%

More info and screens

0

5. Dividend

5.1 Amount

NVTA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INVITAE CORP

NYSE:NVTA (2/5/2024, 7:40:05 PM)

0.0891

-0.3 (-77.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-08 2023-11-08/amc
Earnings (Next)02-21 2024-02-21/amc
Inst Owners0.08%
Inst Owner Change0%
Ins Owners3.24%
Ins Owner Change0%
Market Cap25.53M
Revenue(TTM)481.60M
Net Income(TTM)-1.44B
Analysts46.15
Price Target0.72 (708.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)44.39%
Min EPS beat(2)19.77%
Max EPS beat(2)69%
EPS beat(4)4
Avg EPS beat(4)33.24%
Min EPS beat(4)7.42%
Max EPS beat(4)69%
EPS beat(8)6
Avg EPS beat(8)21.36%
EPS beat(12)6
Avg EPS beat(12)8.33%
EPS beat(16)9
Avg EPS beat(16)6.63%
Revenue beat(2)0
Avg Revenue beat(2)-1.81%
Min Revenue beat(2)-1.89%
Max Revenue beat(2)-1.72%
Revenue beat(4)0
Avg Revenue beat(4)-1.47%
Min Revenue beat(4)-1.89%
Max Revenue beat(4)-0.98%
Revenue beat(8)0
Avg Revenue beat(8)-2.01%
Revenue beat(12)3
Avg Revenue beat(12)-1.95%
Revenue beat(16)6
Avg Revenue beat(16)0.31%
PT rev (1m)-45.8%
PT rev (3m)-52.03%
EPS NQ rev (1m)-14.83%
EPS NQ rev (3m)-8.11%
EPS NY rev (1m)0%
EPS NY rev (3m)20.44%
Revenue NQ rev (1m)-6.28%
Revenue NQ rev (3m)-6.48%
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-0.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 0.53
EPS(TTM)-1.11
EYN/A
EPS(NY)-0.9
Fwd EYN/A
FCF(TTM)-0.87
FCFYN/A
OCF(TTM)-0.83
OCFYN/A
SpS1.68
BVpS-3.78
TBVpS-3.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -269.22%
ROE N/A
ROCE 483.52%
ROIC 381.98%
ROICexc 1178.47%
ROICexgc 1178.47%
OM 378.2%
PM (TTM) N/A
GM 27.14%
FCFM N/A
ROA(3y)-61.41%
ROA(5y)-52.18%
ROE(3y)-1031.52%
ROE(5y)-647.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.59%
GM growth 5Y-3.73%
F-Score3
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 0.68
Cap/Depr 6.96%
Cap/Sales 1.99%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.39
Quick Ratio 2.25
Altman-Z -3.51
F-Score3
WACC2.22%
ROIC/WACC172.06
Cap/Depr(3y)54.7%
Cap/Depr(5y)66.37%
Cap/Sales(3y)10.13%
Cap/Sales(5y)8.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.19%
EPS Next Y53.25%
EPS Next 2Y26.21%
EPS Next 3Y18.34%
EPS Next 5Y12.71%
Revenue 1Y (TTM)-7.37%
Revenue growth 3Y33.54%
Revenue growth 5Y49.91%
Sales Q2Q%-9.21%
Revenue Next Year-6.03%
Revenue Next 2Y0.81%
Revenue Next 3Y3.75%
Revenue Next 5Y3.73%
EBIT growth 1Y329.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year65.63%
EBIT Next 3Y20.35%
EBIT Next 5Y16.33%
FCF growth 1Y54.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.11%
OCF growth 3YN/A
OCF growth 5YN/A

INVITAE CORP / NVTA FAQ

Can you provide the ChartMill fundamental rating for INVITAE CORP?

ChartMill assigns a fundamental rating of 2 / 10 to NVTA.


What is the valuation status of INVITAE CORP (NVTA) stock?

ChartMill assigns a valuation rating of 1 / 10 to INVITAE CORP (NVTA). This can be considered as Overvalued.


Can you provide the profitability details for INVITAE CORP?

INVITAE CORP (NVTA) has a profitability rating of 2 / 10.


Can you provide the financial health for NVTA stock?

The financial health rating of INVITAE CORP (NVTA) is 3 / 10.


What is the earnings growth outlook for INVITAE CORP?

The Earnings per Share (EPS) of INVITAE CORP (NVTA) is expected to grow by 53.25% in the next year.